Gå direkt till huvudinnehållet

Arytmogen högerkammarkardiomyopati (ARVC)

Senast uppdaterad: Publicerad:
Sakkunnig:
  • Anderson EL. Arrhythmogenic right ventricular dysplasia. Am Fam Physician 2006; 73: 1391-8.
  1. Gemayel C, Pelliccia A, Thompson PD. Arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2001; 38: 1773. PubMed  
  2. Priori SG, Aliot E, Blomstrom-Lundqvist C, et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2001; 22: 1374. European Heart Journal  
  3. Sen-Chowdhry S, Lowe MD, Sporton SC, McKenna WJ. Arrhythmogenic right ventricular cardiomyopathy: clinical presentation, diagnosis, and management. Am J Med 2004; 117: 685. PubMed  
  4. Corrado D, Link MS, Calkins H. Arrhythmogenic Right Ventricular Cardiomyopathy. N Engl J Med. 2017 Jan 5;376(1):61-72. PMID: 28052233. PubMed  
  5. Richardson P, McKenna WJ, Bristow M, et al. Report of the 1995 WHO/ISFC Task Force on the definition and classification of the cardiomyopathies. Circulation 1996; 93: 841. Circulation  
  6. Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation 1982; 65: 384-98. Circulation  
  7. Ananthasubramaniam K, Khaja F. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: review for the clinician. Prog Cardiovasc Dis 1998; 41: 237-46. PubMed  
  8. Rossi PA. Arrhythmogenic right ventricular dysplasia-clinical features. Eur Heart J 1989; 10(suppl D): 7-9.
  9. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988; 318: 129-33. New England Journal of Medicine  
  10. Corrado D, Thiene G, Nava A, Rossi L, Pennelli N. Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. Am J Med 1990; 89: 588-96. PubMed  
  11. Hosey RG, Armsey TD. Sudden cardiac death. Clin Sports Med 2003; 22: 51-66. PubMed  
  12. Peters S, Peters H, Thierfelder L. Risk stratification of sudden cardiac death and malignant ventricular arrhythmias in right ventricular dysplasia-cardiomyopathy. Int J Cardiol 1999; 71: 243-50. PubMed  
  13. Ahmad F. The molecular genetics of arrhythmogenic right ventricular dysplasia-cardiomyopathy. Clin Invest Med 2003; 26: 167-78. PubMed  
  14. Wlodarska EK, Konka M, Kepski R, Zaleska T, Ploski R, Ruzyllo W, et al. Familial form of arrhythmogenic right ventricular cardiomyopathy. Kardiol Pol 2004; 60: 1-14. PubMed  
  15. Marcus F, Towbin JA, Zareba W, Moss A, Calkins H, Brown M, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a multidisciplinary study design and protocol. Circulation 2003; 107: 2975-8. Circulation  
  16. Fontaine G, Fontaliran F, Hébert JL, Chemla D, Zenati O, Lecarpentier Y, et al. Arrhythmogenic right ventricular dysplasia. Annu Rev Med 1999; 50: 17-35. PubMed  
  17. Saliba WI, Natale A. Ventricular tachycardia syndromes. Med Clin North Am 2001; 85: 267-304. PubMed  
  18. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 1994; 71: 215-8. PubMed  
  19. Bomma C, Rutberg J, Tandri H, Nasir K, Roguin A, Tichnell C, et al. Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Electrophysiol 2004; 15: 300-6. PubMed  
  20. Hamid MS, Norman M, Quraishi A, Firoozi S, Thaman R, Gimeno JR, et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 2002; 40: 1445-50. PubMed  
  21. Coumbe A, Perez-Martinez AL, Fegan AW, Hill IR. Arrhythmogenic right ventricular dysplasia (ARVD): an overlooked and underdiagnosed condition? Med Sci Law 1997; 37: 262-5. PubMed  
  22. O'Donnell D, Cox D, Bourke J, Mitchell L, Furniss S. Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia. Eur Heart J 2003; 24: 801-10. European Heart Journal  
  23. Iesaka Y, Hiroe M, Aonuma K, Nitta J, Nogami A, Tokunaga T, et al. Usefulness of electrophysiologic study and endomyocardial biopsy in differentiating arrhythmogenic right ventricular dysplasia from idiopathic right ventricular tachycardia. Heart Vessels 1990; 5(suppl): 65-9.
  24. Niroomand F, Carbucicchio C, Tondo C, Riva S, Fassini G, Apostolo A, et al. Electrophysiological characteristics and outcome in patients with idiopathic right ventricular arrhythmia compared with arrhythmogenic right ventricular dysplasia. Heart 2002; 87: 41-7. PubMed  
  25. Stevenson I, Kalman J. Magnetic resonance imaging in the diagnosis of arrhythmogenic right ventricular cardiomyopathy: the gold standard or just another imaging modality? J Interv Card Electrophysiol 2004; 10: 27-9. PubMed  
  26. Lopez-Fernandez T, Garcia-Fernandez MA, Perez David E, Moreno Yanguela M. Usefulness of contrast echocardiography in arrhythmogenic right ventricular dysplasia. J Am Soc Echocardiogr 2004; 17: 391-3. PubMed  
  27. White JB, Razmi R, Nath H, Kay GN, Plumb VJ, Epstein AE. Relative utility of magnetic resonance imaging and right ventricular angiography to diagnose arrhythmogenic right ventricular cardiomyopathy. J Interv Card Electrophysiol 2004; 10: 19-26. PubMed  
  28. Blake LM, Scheinman MM, Higgins CB. MR features of arrhythmogenic right ventricular dysplasia. AJR Am J Roentgenol 1994; 162: 809-12. PubMed  
  29. Ricci C, Longo R, Pagnan L, Dalla Palma L, Pinamonti B, Camerini F, et al. Magnetic resonance imaging in right ventricular dysplasia. Am J Cardiol 1992; 70: 1589-95. PubMed  
  30. Tandri H, Bomma C, Calkins H, Bluemke DA. Magnetic resonance and computed tomography imaging of arrhythmogenic right ventricular dysplasia. J Magn Reson Imaging 2004; 19: 848-58. PubMed  
  31. Auffermann W, Wichter T, Breithardt G, Joachimsen K, Peters PE. Arrhythmogenic right ventricular disease: MR imaging vs angiography. AJR Am J Roentgenol 1993; 161: 549-55. PubMed  
  32. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93: 841-2. Circulation  
  33. Fontaine G, Fontaliran F, Frank R. Arrhythmogenic right ventricular cardiomyopathies: clinical forms and main differential diagnoses. Circulation 1998; 97: 1532-5. Circulation  
  34. Maron BJ, Zipes DP, Kovacs RJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Preamble, principles, and general considerations: A scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015; 66: 2343-9. pmid:26542655 PubMed  
  35. Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation 1992; 86: 29-37. Circulation  
  36. Leclercq JF, Coumel P. Characteristics, prognosis and treatment of the ventricular arrhythmias of right ventricular dysplasia. Eur Heart J 1989; 10(suppl D): 61-7.
  37. Fontaine G, Gallais Y, Fornes P, Hebert JL, Frank R. Arrhythmogenic right ventricular dysplasia/cardiomyopathy. Anesthesiology 2001; 95: 250-4. PubMed  
  38. Fontaine G, Prost-Squarcioni C. Implantable cardioverter defibrillator in arrhythmogenic right ventricular cardiomyopathies. Circulation 2004; 109: 1445-7. Circulation  
  39. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2002; 40: 1703-19. PubMed  
  40. Roguin A, Bomma CS, Nasir K, Tandri H, Tichnell C, James C, et al. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2004; 43: 1843-52. PubMed  
  41. Corrado D, Leoni L, Link MS, Della Bella P, Gaita F, Curnis A, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003; 108: 3084-91. Circulation  
  42. Gear K, Marcus F. Arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 2003; 107: 31-3. Circulation  
  43. Harrison TC, Kessler D. Arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Lung 2001; 30: 360-9. PubMed  
  • Bert Andersson, docent och överläkare, Kardiologkliniken, Sahlgrenska universitetssjukhuset, Göteborg

Tidigare sakkunniga

  • Terje Johannessen, professor i allmänmedicin, Institutt for samfunnsmedisinske fag, Norges teknisk-naturvitenskapelige universitet, Trondheim